QTc interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus:: a 23-year follow-up

被引:77
作者
Stettler, C.
Bearth, A.
Allemann, S.
Zwahlen, M.
Zanchin, L.
Deplazes, M.
Christ, E. R.
Teuscher, A.
Diem, P. [1 ]
机构
[1] Univ Bern, Inselspital, Div Endocrinol & Diabet, CH-3010 Bern, Switzerland
[2] Univ Bern, Div Epidemiol & Biostat, Dept Social & Prevent Med, Bern, Switzerland
[3] SRO Hosp, Div Cardiol, Langenthal, Switzerland
关键词
cardiovascular disease; diabetes mellitus; heart rate; mortality; QT interval; risk factors;
D O I
10.1007/s00125-006-0483-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We evaluated the association of QT interval corrected for heart rate (QT(c)) and resting heart rate (rHR) with mortality (all-causes, cardiovascular, cardiac, and ischaemic heart disease) in subjects with type 1 and type 2 diabetes. We followed 523 diabetic patients (221 with type 1 diabetes, 302 with type 2 diabetes) who were recruited between 1974 and 1977 in Switzerland for the WHO Multinational Study of Vascular Disease in Diabetes. Duration of follow-up was 22.6 +/- 0.6 years. Causes of death were obtained from death certificates, hospital records, post-mortem reports, and additional information given by treating physicians. In subjects with type 1 diabetes QT(c), but not rHR, was associated with an increased risk of: (1) all-cause mortality (hazard ratio [HR] 1.10 per 10 ms increase in QT(c), 95% CI 1.02-1.20, p=0.011); (2) mortality due to cardiovascular (HR 1.15, 1.02-1.31, p=0.024); and (3) mortality due to cardiac disease (HR 1.19, 1.03-1.36, p=0.016). Findings for subjects with type 2 diabetes were different: rHR, but not QT(c) was associated with mortality due to: (1) all causes (HR 1.31 per 10 beats per min, 95% CI 1.15-1.50, p < 0.001); (2) cardiovascular disease (HR 1.43, 1.18-1.73, p < 0.001); (3) cardiac disease (HR 1.45, 1.19-1.76, p < 0.001); and (4) ischaemic heart disease (HR 1.52, 1.21-1.90, p < 0.001). Effect modification of QT(c) by type 1 and rHR by type 2 diabetes was statistically significant (p < 0.05 for all terms of interaction). QT(c) is associated with long-term mortality in subjects with type 1 diabetes, whereas rHR is related to increased mortality risk in subjects with type 2 diabetes.
引用
收藏
页码:186 / 194
页数:9
相关论文
共 48 条
[41]   Prevalence of increased QT interval duration and dispersion in type 2 diabetic patients and its relationship with coronary heart disease: a population-based cohort [J].
Veglio, M ;
Bruno, G ;
Borra, M ;
Macchia, G ;
Bargero, G ;
D'Errico, N ;
Pagano, GF ;
Cavallo-Perin, P .
JOURNAL OF INTERNAL MEDICINE, 2002, 251 (04) :317-324
[42]   DOES ABNORMAL QT INTERVAL PROLONGATION REFLECT AUTONOMIC DYSFUNCTION IN DIABETIC-PATIENTS QTC INTERVAL MEASURE VERSUS STANDARDIZED TESTS IN DIABETIC AUTONOMIC NEUROPATHY [J].
VEGLIO, M ;
CHINAGLIA, A ;
BORRA, M ;
PERIN, PC .
DIABETIC MEDICINE, 1995, 12 (04) :302-306
[43]   QT interval prolongation and mortality in type 1 diabetic patients - A 5-year cohort prospective study [J].
Veglio, M ;
Sivieri, R ;
Chinaglia, A ;
Scaglione, L ;
Cavallo-Perin, P .
DIABETES CARE, 2000, 23 (09) :1381-1383
[44]   The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group [J].
Veglio, M ;
Borra, M ;
Stevens, LK ;
Fuller, JH ;
Perin, PC .
DIABETOLOGIA, 1999, 42 (01) :68-75
[45]   Diabetic autonomic neuropathy [J].
Vinik, AI ;
Maser, RE ;
Mitchell, BD ;
Freeman, R .
DIABETES CARE, 2003, 26 (05) :1553-1579
[46]   Excess mortality in incident cases of diabetes mellitus aged 15 to 34 years at diagnosis:: a population-based study (DISS) in Sweden [J].
Waernbaum, I ;
Blohmé, G ;
Östman, J ;
Sundkvist, G ;
Eriksson, JW ;
Arnqvist, HJ ;
Bolinder, J ;
Nyström, L .
DIABETOLOGIA, 2006, 49 (04) :653-659
[47]   Electrocardiographic QT interval prolongation and risk of primary cardiac arrest in diabetic patients [J].
Whitsel, EA ;
Boyko, EJ ;
Rautaharju, PM ;
Raghunathan, TE ;
Lin, DY ;
Pearce, RM ;
Weinmann, SA ;
Siscovick, DS .
DIABETES CARE, 2005, 28 (08) :2045-2047
[48]  
1985, DIABETOLOGIA S, V28, P615